GLIOMA

This study compares two radiation methods—proton beam and photon beam (IMRT)—in 120 people with slow-growing brain tumors (IDH-mutant gliomas). The goal is to see which better preserves memory and thinking over time. Participants are randomly assigned to one type of radiation and…

This phase 2 trial tests whether combining two drugs—olaparib and durvalumab—can shrink or control solid tumors that have an IDH mutation. The study includes adults with certain brain tumors (glioma) or bile duct cancer (cholangiocarcinoma) that have not responded well to prior t…

This early-stage trial tests a new drug called BI 764532 in 20 adults with a type of brain tumor (glioma) that has a specific marker called DLL3 and hasn't improved with prior treatment. The drug is designed to link cancer cells to immune cells, helping the body fight the tumor. …

This study tests whether giving pregabalin before brain tumor surgery can safely reduce pressure inside the skull. One hundred adults will receive either pregabalin or a placebo before and on the morning of surgery. Researchers will measure pressure using a painless eye ultrasoun…

This early-stage trial tests a new surgical approach for recurrent glioblastoma, an aggressive brain cancer. After standard tumor removal, surgeons place a piece of abdominal tissue (omentum) into the brain cavity to bypass the blood-brain barrier. The study involves 10 adults an…

This phase 2 trial tests whether adding the targeted drug abemaciclib to standard chemotherapy (temozolomide) helps children and young adults with newly diagnosed high-grade glioma live longer without their cancer growing. About 45 participants will receive either the combination…

This early-stage study tests an oral drug called LY3410738 in people with advanced solid tumors (like bile duct cancer, cartilage cancer, or brain tumors) that have specific IDH1 or IDH2 mutations. The main goal is to find a safe dose and see if the drug can shrink tumors. About …

This study tests a new oncolytic virus (Ad-TD-nsIL12) in 40 adults with high-grade glioma, a fast-growing brain tumor. The virus is designed to infect and kill cancer cells while boosting the immune system. The main goal is to see how many patients survive at least 12 months afte…

This early-phase trial tests whether adding the drug AZD1390 to standard radiation therapy can help people with a fast-growing brain tumor called glioblastoma (grade 4 glioma). The study includes both newly diagnosed and recurrent patients. First, researchers measure how much dru…

This early-phase trial tests the drug niraparib (Zejula) in people with two types of brain cancer: newly diagnosed glioblastoma and recurrent glioma with specific genetic changes (IDH mutation and ATRX loss). The study first checks if the drug reaches the tumor tissue, then gives…

This early-stage study tests a genetically engineered virus (rQNestin34.5v.2) that is injected directly into recurrent brain tumors to see if it is safe and what dose works best. About 62 adults with certain types of brain cancer that have come back or worsened are taking part. T…

This pilot study tests whether the drug pembrolizumab can shrink or control recurrent malignant glioma, a type of brain cancer, in people whose tumors have many genetic mutations (hypermutator phenotype). The 27 participants have already had radiation and chemotherapy. The goal i…

This early-phase study tests a new drug called DS-1001b in 47 people with a specific type of brain tumor (glioma) that has an IDH1 gene mutation and has come back after standard treatments. The main goal is to check the drug's safety and how the body processes it, while also look…

This early-stage trial tests a personalized cell therapy called IL13Rα2 CAR-T for people with recurrent grade 4 glioma, an aggressive brain cancer. The treatment involves collecting a patient's immune cells, engineering them to target a protein on tumor cells, and infusing them b…

This early-phase study tests whether specially engineered immune cells (CAR T cells) can be safely given directly into the brain or spinal fluid of children and young adults with HER2-positive brain tumors that have come back or not responded to standard treatments. The therapy a…

This early-phase trial tests whether a drug called rhIL-7-hyFc can safely increase lymphocyte counts in people with high-grade glioma who have low immune cells after standard radiation and chemotherapy. About 42 participants will receive either the drug or a placebo by injection.…

This study tests if the immunotherapy drug nivolumab can stop or slow the growth of certain brain tumors (gliomas) that have IDH mutations. Researchers are especially interested in tumors with many genetic changes (hypermutator phenotype). The trial involves 62 adults who receive…

This program gave patients with glioma (a type of brain tumor) access to a special imaging agent called 18F-FET. It was used with PET scans to help doctors tell the difference between actual tumor growth and changes caused by previous treatments. The goal was to improve treatment…

This study tests a device called DESI-MS that analyzes tissue during brain tumor surgery to tell cancerous from healthy tissue. Researchers will check tissue samples from 285 adults undergoing glioma surgery. The goal is to see if this tool can give surgeons faster, more accurate…

This study is testing a new type of MRI scan that looks at sodium and other chemicals in the brain to get a clearer picture of brain tumors (gliomas). The goal is to improve how doctors detect, diagnose, and track these tumors. The study includes healthy volunteers and people wit…

This study tests whether a couple-based Hatha yoga program can improve quality of life, fatigue, distress, and sleep for people with high-grade glioma undergoing radiation therapy and their partners. About 216 couples will participate, with some receiving the yoga program and oth…

This study tests a skills training program for family members caring for someone with a high-grade glioma. The goal is to see if the training can reduce caregiver stress, improve their confidence, and help patients feel better. About 124 caregivers and patients will take part at …

This study tests whether a non-invasive magnetic brain stimulation technique (nrTMS) can help people recover movement in their arm or hand after surgery for a brain tumor called glioma. Forty-three participants who still have weakness 7 days after surgery will receive either real…

This phase II trial, called MATCH, is testing whether treating cancer based on the genetic makeup of a patient's tumor works better than standard treatments. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to prior therapy are …

This study investigates whether a simple blood test can help diagnose and monitor low-grade gliomas, a type of slow-growing brain tumor. Researchers will collect blood samples from 50 patients undergoing brain surgery to look for circulating tumor cells and other markers. The goa…

This study tracks a substance called 2-HG in the brains of people with a type of brain cancer (glioma) that has specific gene changes. By using special MRI scans over time, researchers hope to learn how and when these tumors become more aggressive. About 42 adults will have regul…

This study follows 71 glioma patients before and after radiation therapy to see how their thinking skills change. Researchers use special brain scans (RS-fMRI) to map which brain networks are most harmed by radiation. The goal is to learn which areas to avoid during treatment pla…

This early study tests whether the drug abemaciclib can be measured inside brain tumors after being taken by mouth. One person aged 18–39 with a recurrent high-grade glioma or diffuse midline glioma will take the drug for 4.5 days before surgery. During surgery, a small tube is p…

This study looks at whether it's possible for people with a new brain tumor (glioma) to wear a step counter like a Fitbit or pedometer during radiation therapy. About 50 participants will track their steps for 6 weeks to see if it helps improve their quality of life and symptoms.…

This study tests a new PET scan method that looks at two things at once: oxygen levels and cell growth in high-grade brain tumors. The goal is to see if these scans can help doctors understand which tumors might resist standard treatment. Only 8 adults with suspected high-grade g…

This study looks at whether special MRI scans can be used safely during surgery to remove brain tumors called gliomas. Researchers will try two advanced imaging techniques before and during the operation. The goal is to see if these scans are possible and to track any complicatio…

This study tests a new imaging technique called Deuterium Metabolic Imaging (DMI) to see if it can predict how well glioblastoma patients respond to treatment. Ten participants will drink a special glucose tracer before MRI scans. The goal is to improve treatment decisions, but t…

This study tests a new way to measure brain metabolism using a special glucose drink and MRI scans. Researchers will compare healthy volunteers and people with glioma (a type of brain tumor) to see if the technique can detect differences in energy use. The goal is to improve imag…